Document is current
Any future updates will be listed below
-
Authors
Smith, Keisha
Pace, Amy https://orcid.org/0000-0003-4217-1345
Ortiz, Stephan https://orcid.org/0000-0003-1108-0336
Kazani, Shamsah https://orcid.org/0000-0002-1234-8253
Rottinghaus, Scott
-
Funding
Funding for this research was provided by:
Alexion Pharmaceuticals
- License Information
-
More Information
Article History
Received: 19 June 2020
Accepted: 22 June 2020
First Online: 13 July 2020
Ethics approval and consent to participate
: Name of the ethics committee that approved the study: Western Institutional Review Board (WIRB).File number/reference number: IRB tracking number 20201059; Work Order number 1-1297217-1Date of Approval: 23 Apr 2020Link to public listing of the ethical approval (if available). Not AvailableWe certify that this study will be conducted in accordance with the protocol and with the consensus ethical principles derived from international guidelines including the Declaration of Helsinki and Council for International Organizations of Medical Sciences (CIOMS) International Ethical Guidelines, Applicable International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Good Clinical Practice (GCP) Guidelines, and applicable laws and regulations.Patients or their legally acceptable representative must be consented. If allowable per local regulations, exceptions may be granted in cases where the patient is unable to provide informed consent.
: Not applicable.
: KS, AP, SO, SK, and SR are employees and stockholders of Alexion Pharmaceuticals.
